Skip to content

Comprehensive effect observation of clinical application of sufentanil and study of morning and afternoon chronopharmacology

Comprehensive effect observation of clinical application of sufentanil and study of morning and afternoon chronopharmacology

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100053467
Enrollment
Unknown
Registered
2021-11-22
Start date
2021-11-23
Completion date
Unknown
Last updated
2022-10-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Interventions

Morning Group:Sufentanil was given 0.15ug/kg intravenously
Afternoon Group:Sufentanil was given 0.15ug/kg intravenously

Sponsors

Department of Anesthesiology, The Second Affiliated Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-65 years; 2. Patients who need to be prepared for general anesthesia in the pre-anesthesia room for elective surgery; 3. ASA I-II grade; 4. 18.5 <= body mass index (BMI)<= 28; 5. Voluntarily participated and signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Long-term use of analgesics, psychiatric drugs (including opioids, NSAIDs, sedatives, antidepressants), alcohol abusers with chronic pain; 2. Preoperative liver and kidney function (ALT, AST, BUN, Cr) abnormally increased; 3. There is a history of abnormal surgical anesthesia recovery in the past; 4. A history of opioid allergy; 5. Suffering from esophageal reflux disease; 6. Sedatives, antiemetics, and antipruritic drugs were used 24 hours before surgery; 7. Difficult intubation is expected; 8. Perform liver surgery; 9. Taking monoamine oxidase inhibitory drugs or antidepressants within 15 days; 10. COPD subjects; 11. Pregnant women or mothers; 12. Participated in other drug trials within three months.

Design outcomes

Primary

MeasureTime frame
Stress pain threshold;

Secondary

MeasureTime frame
Invasive arterial blood pressure;Heart rate;pulse oxygen saturation;arterial carbon dioxide partial pressure;arterial partial pressure of oxygen;modified observer's assessment of alert /sedation;Region of interests ventilation ROI1,ROI2,ROI3,ROI4;respiratory rate;

Countries

China

Contacts

Public ContactDan Ling

Department of Anesthesiology, The Second Affiliated Hospital of Chongqing Medical University

danling1@sohu.com+86 13983072922

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026